Skip to content

Clareon™ CNWTT3 (UDI 00380652468480)Recalls & reported problems

Alcon Laboratories, Inc. · STERILE UV and Blue Light Filtering Hydrophobic Acrylic Foldable Diffractive Aspheric Toric Posterior Chamber Intraocular Lens · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380652468480), received between May 19, 2023 and May 26, 2026 — classified as 3 injuries, 1 malfunction.

The most frequently reported specific device problem is “Malposition of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 1 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Malposition of Device1
  • Scratched Material1

Patient problems

  • Visual Impairment2
  • Blurred Vision1
  • Capsular Bag Tear1
  • Corneal Edema1
  • Insufficient Information1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 26, 2026Adverse Event Without Identified Device or Use Problem

    A NON HEALTH CARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT FOUND IT TOO HARD TO DRIVE AT NIGHT. CLINICAL REASON BEING MENTIONED AS SURGEON CHANGED DIFFRACTIVE LENS TO NON DIFFRACTIVE MONOFOCAL LENS. THE IOL WAS EXPLANTED AND EXCHANGED FOR AN UNKNOWN ATIOL (ADVANCED TECHNOLOGY INTRAOCULAR LENS) IN THE SECONDARY IMPLANT PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED, BUT NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Visual Impairment

    MAUDE report 25278716 ↗
  • MalfunctionJul 1, 2025Scratched Material; Scratched Material

    A HEALTHCARE PROFESSIONAL REPORTED THAT DURING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE LENS WAS SCRATCHED AND LENS DAMAGE BY COMPANY HANDPIECE INJECTOR· THE LENS WAS REMOVED DURING INITIAL PROCEDURE AND REPLACED WITH ANOTHER LENS.

    Patient problems: Insufficient Information

    MAUDE report 22372610 ↗
  • InjuryNov 21, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING CATARACT SURGERY WITH INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, PATIENT HAD EXTREMELY POOR VISION AND POOR VISUAL OUTCOME. ALSO, THERE WAS DECREASE IN BOTH DISTANCE AND NEAR VISION SINCE SURGERY. STATED VISION WAS BETTER PRIOR TO CATARACT SURGERY. THE LENS WAS EXCHANGED WITH COMPANY ANOTHER MODEL IOL AFTER THE INITIAL IMPLANT PROCEDURE. CLINICAL REASON FOR THE EXPLANT WAS PATIENT UNABLE TO TOLERATE IOL. THE PATIENT HAD PERSISTENT CORNEAL EDEMA FOLLOWING IOL EXCHANGE. THE PATIENT'S ISSUE WAS RESOLVING. IN THE SURGEON'S OPINION PRODUCT CONTRIBUTED TO EVENT.

    Patient problems: Blurred Vision; Corneal Edema; Visual Impairment

    MAUDE report 20748440 ↗
  • InjuryMay 19, 2023Malposition of Device; Malposition of Device

    A PHYSICIAN REPORTED THAT FOLLOWING THE INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE IOL WAS DECENTERED. THE IOL EXCHANGED IN A SECONDARY PROCEDURE WITH MONOFOCAL IOL. ADDITIONAL INFORMATION RECEIVED AND STATED THAT, POSTERIOR CAPSULAR TEAR LED TO DECENTERING OF IOL.

    Patient problems: Capsular Bag Tear

    MAUDE report 16962036 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page